Epidermal growth factor receptors in vascular endothelial cells contribute to functional hyperemia in the brain.

Functional hyperemia cerebral small vessel diseases (cSVD) epidermal growth factor receptor (EGFR) phosphatidylinositol 4,5-bisphosphate (PIP2) vascular endothelial cells

Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
17 Sep 2023
Historique:
pubmed: 25 9 2023
medline: 25 9 2023
entrez: 25 9 2023
Statut: epublish

Résumé

Functional hyperemia - activity-dependent increases in local blood perfusion - underlies the on-demand delivery of blood to regions of enhanced neuronal activity, a process that is crucial for brain health. Importantly, functional hyperemia deficits have been linked to multiple dementia risk factors, including aging, chronic hypertension, and cerebral small vessel disease (cSVD). We previously reported crippled functional hyperemia in a mouse model of genetic cSVD that was likely caused by depletion of phosphatidylinositol 4,5-bisphosphate (PIP

Identifiants

pubmed: 37745396
doi: 10.1101/2023.09.15.557981
pmc: PMC10516026
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL142888
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM135007
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL140027
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS128963
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110656
Pays : United States

Commentaires et corrections

Type : UpdateIn

Déclaration de conflit d'intérêts

Conflict of Interest: All authors have no conflict to declare.

Auteurs

Hannah R Ferris (HR)

Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT, USA.

David C Hill-Eubanks (DC)

Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT, USA.

Mark T Nelson (MT)

Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT, USA.
Vermont Center for Cardiovascular and Brain Health, Larner College of Medicine University of Vermont, Burlington, VT, USA.
Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.

George C Wellman (GC)

Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT, USA.

Masayo Koide (M)

Department of Pharmacology, Larner College of Medicine University of Vermont, Burlington, VT, USA.
Vermont Center for Cardiovascular and Brain Health, Larner College of Medicine University of Vermont, Burlington, VT, USA.

Classifications MeSH